Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy-Reference-Cited by-同舟云学术

Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy

Published:2019-06-18 Issue:1 Volume:235 Page:31-64
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Yaghoubi Sajad¹,Karimi Mohammad Hossein²,Lotfinia Majid³⁴,Gharibi Tohid⁵⁶^ORCID,Mahi‐Birjand Motahare⁷,Kavi Esmaeil⁸,Hosseini Fahimeh⁹,Sineh Sepehr Koushan¹⁰,Khatami Mehrdad¹¹,Bagheri Nader¹²^ORCID,Abdollahpour‐Alitappeh Meghdad⁸^ORCID

Affiliation:

1. Department of Clinical Microbiology Iranshahr University of Medical Sciences Iranshahr Iran

2. Transplant Research Center Shiraz University of Medical Sciences Shiraz Iran

3. Physiology Research Center Kashan University of Medical Sciences Kashan Iran

4. Core Research Lab Kashan University of Medical Sciences Kashan Iran

5. Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran

6. Department of Immunology, Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

7. Infectious Disease Research Center Birjand University of Medical Sciences Birjand Iran

8. Department of Nursing, School of Nursing Larestan University of Medical Sciences Larestan Iran

9. Department of Microbiology, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

10. Laboratory Sciences Research Center Golestan University of Medical Sciences Gorgan Iran

11. NanoBioelectrochemistry Research Center Bam University of Medical Sciences Bam Iran

12. Cellular and Molecular Research Center, Basic Health Sciences Institute Shahrekord University of Medical Sciences Shahrekord Iran

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28967

Reference220 articles.

1. Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action

2. A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line

3. Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes

4. Camptothecin analogues with enhanced antitumor activity at acidic pH

5. Antibody–Drug Conjugate Payloads

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Technological and Intellectual Property Trends in Antibody–Drug Conjugate Research;Pharmaceutics;2024-02-03

2. Tubulin inhibitors. Selected scaffolds and main trends in the design of novel anticancer and antiparasitic agents;Bioorganic Chemistry;2024-02

3. Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer;Annual Review of Medicine;2024-01-29

4. Therapeutic synthetic and natural materials for immunoengineering;Chemical Society Reviews;2024

5. Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions;Archives of Pharmacal Research;2023-12-28